A shadow economy for unapproved slimming medications is being driven by social media fitness personalities and sellers on messaging platforms, according to new investigations.
Experimental Treatment Gaining Traction Online
The experimental drug, which remains in clinical trials, is being advertised by online personalities for its alleged weight-reducing properties. Followers are urged to contact these profiles privately for source information, while also obtaining promotional offers.
Thriving Trade on Social Networks
Separately, a robust trade exists on messaging services, where communities with thousands of members share “before and after” photos, injection guides and assertions of next-day UK delivery. Sellers promote the substance there before directing buyers to WhatsApp for purchases.
Learning About Retatrutide
This medication is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could assist patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.
Medical Professionals Voice Worries
Nevertheless, doctors and chemists have warned that the distribution of what is still an unlicensed drug in the UK is a cause for concern and could result in users administering substances of unknown origin.
Some experts said the popularity for retatrutide could be linked to the increasing price of licensed slimming treatments such as Mounjaro.
Legal Position and Implementation
Marketing the unapproved drug on social media or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that cannot be promoted or distributed for human use under the Human Medicines Regulations 2012.
Some influencers try to circumvent the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and distribution can still breach medicines, advertising, and consumer regulations, risking fines, legal action or prison.
Platform Reaction and Content Removal
According to the social media company, the platform has taken down violative content and prohibited associated keywords and search suggestions. The organization said it was dedicated to keeping the platform safe and allocating resources in enhancing enforcement strategies.
Online Marketplace Activities
Research also discovered groups with up to nine thousand members selling retatrutide using the platform's integrated discovery tool, which functions like a online catalog. Typing “retatrutide” instantly brings up channels with numerous of users, filled with photos of slimming results, positive testimonials and step-by-step instructions for mixing or injecting at home.
Within moments of joining one group, a seller posted WhatsApp details, where the majority of purchases occur. The vendor provided an guidebook and guaranteed delivery within 48 hours. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another shared a image of a supposed testing documentation. None inquired about weight, medical conditions or past usage.
Product Details and Costs
Inside these groups, messages display black plastic parcels with Royal Mail labels, claiming to contain new batches. One communication read: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, mixed at home with purified liquid, or pre-filled pens usually priced at 160 pounds for 20mg. When questioned how long a pen should be used, sellers give conflicting responses ranging from a several days to “depends on your body”.
Platform Moderation and Safety Measures
A spokesperson for Telegram said it regularly monitored dangerous content on its platform including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“Individuals are injecting materials they can’t verify. Even if the science behind this drug is sound, these digital products may not contain what they advertise,” stated a pharmacy expert, the head of pharmacy at Chemist4U.
Dr Crystal Wyllie of an online medical service connected the increase in interest to current price rises for approved slimming medications such as Mounjaro. “With costs increasing, patients are turning to online platforms. But fake injections are highly risky. You cannot know what’s inside or whether the environment they were made in was clean,” she said.
Her team has already encountered individuals injured by self-injection from unconfirmed suppliers. “We understand the frustration, but purchasing from messaging apps or communication platforms is gambling with your well-being,” said Wyllie. “These materials could be impure or improperly measured.”
Manufacturer Position
A spokesperson from the pharmaceutical company said the substance was in third stage clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a Lilly investigational product not yet authorized … may subject patients to possibly significant medical dangers”.
